These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1398 related articles for article (PubMed ID: 19573731)

  • 1. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome.
    Noda T; Shimizu W; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    Eur Heart J; 2004 Dec; 25(23):2149-54. PubMed ID: 15571831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.
    Yamaguchi M; Shimizu M; Ino H; Terai H; Uchiyama K; Oe K; Mabuchi T; Konno T; Kaneda T; Mabuchi H
    Clin Sci (Lond); 2003 Dec; 105(6):671-6. PubMed ID: 12857349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast and slow torsade de pointes--electrocardiographic characteristics.
    Kukla P; Słowiak-Lewińska T; Szczuka K; Plato A; Bromblik A; Hajduk B; Kluczewski M; Przewor M
    Kardiol Pol; 2004 Apr; 60(4):342-7. PubMed ID: 15226783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The site of origin of torsade de pointes.
    Birati EY; Belhassen B; Bardai A; Wilde AA; Viskin S
    Heart; 2011 Oct; 97(20):1650-4. PubMed ID: 21561894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
    Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
    Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rule of bigeminy revisited: analysis in sudden cardiac death syndrome.
    Lerma C; Lee CF; Glass L; Goldberger AL
    J Electrocardiol; 2007 Jan; 40(1):78-88. PubMed ID: 17069837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical observation on pause-dependent long QT syndrome and torsade de pointes ventricular tachycardia].
    Song YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):349-51, 389. PubMed ID: 1307971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
    Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
    Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications.
    Tan HL; Bardai A; Shimizu W; Moss AJ; Schulze-Bahr E; Noda T; Wilde AA
    Circulation; 2006 Nov; 114(20):2096-103. PubMed ID: 17088455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
    Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
    Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II.
    Raviña T; Gutierrez J; Raviña P
    Int J Cardiol; 2007 Mar; 116(2):272-5. PubMed ID: 16859777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization.
    Yamauchi M; Watanabe E; Yasui K; Takeuchi H; Terasawa T; Sawada K; Hishida H; Kodama I
    Int J Cardiol; 2005 Aug; 103(1):92-7. PubMed ID: 16061129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.